Positron emission tomography (PET) with gallium‐68 prostate‐specific membrane antigen (68Ga‐PSMA) has emerged as a promising imaging modality for evaluating prostate cancer (PC). This evidence concerns the gene FOLH1 and pachyonychia congenita.